flumazenil has been researched along with Dyslipidemias in 2 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity-induced metabolic syndrome is a multiple risk factor for cardiovascular (CV) risk factors and type 2 diabetes, and ethnic minorities seem to have unfavourable medical risk factors in general more frequently than majority populations." | 1.40 | Prevalence of cardiovascular risk factors in relation to metabolic syndrome in the Roma population compared with the non-Roma population in the eastern part of Slovakia. ( Babcák, M; Babinská, I; Cecetková, B; Drazilová, S; Fedacko, J; Gecková, AM; Janicko, M; Jankajová, M; Jarcuska, P; Kalanin, P; Kmec, J; Mareková, M; Pazinka, P; Pella, D; Pella, J; Sabol, F; Siegfried, L; Veselíny, E, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedacko, J | 1 |
| Pella, D | 1 |
| Jarcuska, P | 2 |
| Siegfried, L | 1 |
| Janicko, M | 1 |
| Veselíny, E | 1 |
| Pella, J | 1 |
| Sabol, F | 1 |
| Mareková, M | 1 |
| Gecková, AM | 1 |
| Pazinka, P | 1 |
| Jankajová, M | 1 |
| Kmec, J | 1 |
| Babcák, M | 1 |
| Kalanin, P | 1 |
| Drazilová, S | 1 |
| Babinská, I | 1 |
| Cecetková, B | 1 |
| Kósa, Z | 1 |
| Moravcsik-Kornyicki, Á | 1 |
| Diószegi, J | 1 |
| Roberts, B | 1 |
| Szabó, Z | 1 |
| Sándor, J | 1 |
| Ádány, R | 1 |
2 other studies available for flumazenil and Dyslipidemias
| Article | Year |
|---|---|
Prevalence of cardiovascular risk factors in relation to metabolic syndrome in the Roma population compared with the non-Roma population in the eastern part of Slovakia.
Topics: Adolescent; Adult; Age Distribution; Body Mass Index; Cardiovascular Diseases; Comorbidity; Dyslipid | 2014 |
Prevalence of metabolic syndrome among Roma: a comparative health examination survey in Hungary.
Topics: Adult; Comorbidity; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Health Status; Health Surveys; | 2015 |